Advances in Mammalian cell line development technologies for recombinant protein production.
about
Recent advances in mammalian protein productionEngineering Translation in Mammalian Cell Factories to Increase Protein Yield: The Unexpected Use of Long Non-Coding SINEUP RNAsEfficient production of sTNFRII-gAD fusion protein in large quantity by use of the modified CHO-S cell expression systemStatistical analysis of data from limiting dilution cloning to assess monoclonality in generating manufacturing cell lines.Case report of treatment experience with idursulfase beta (Hunterase) in an adolescent patient with MPS II.Comparative evaluation of heterologous production systems for recombinant pulmonary surfactant protein D.Expression and functional validation of heat-labile enterotoxin B (LTB) and cholera toxin B (CTB) subunits in transgenic rice (Oryza sativa).Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells.Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections.A novel regulatory element (E77) isolated from CHO-K1 genomic DNA enhances stable gene expression in Chinese hamster ovary cellspH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein deliveryIMAC capture of recombinant protein from unclarified mammalian cell feed streamsHuman cell lines for biopharmaceutical manufacturing: history, status, and future perspectives.Matrix attachment region combinations increase transgene expression in transfected Chinese hamster ovary cellsApplicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope.Microbials for the production of monoclonal antibodies and antibody fragments.A short synthetic chimeric sequence harboring matrix attachment region/PSAR2 increases transgene expression in Chinese hamster ovary cells.Regulatory Elements in Vectors for Efficient Generation of Cell Lines Producing Target Proteins.Raman microspectroscopy for the development and screening of recombinant cell lines.High-throughput screening and selection of mammalian cells for enhanced protein production.Recombinant Structural Proteins and Their Use in Future Materials.Cell-Free Systems Based on CHO Cell Lysates: Optimization Strategies, Synthesis of "Difficult-to-Express" Proteins and Future Perspectives.Elastin-like polypeptides: A strategic fusion partner for biologics.Deletion of a telomeric region on chromosome 8 correlates with higher productivity and stability of CHO cell lines.Screening and assessment of performance and molecule quality attributes of industrial cell lines across different fed-batch systems.The influence of bisphenol A on mammalian cell cultivation.Effects of Peptone Supplementation in Different Culture Media on Growth, Metabolic Pathway and Productivity of CHO DG44 Cells; a New Insight into Amino Acid Profiles.Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics.Cell line profiling to improve monoclonal antibody production.Verhulst and stochastic models for comparing mechanisms of MAb productivity in six CHO cell linesThe Use of Transcription Terminators to Generate Transgenic Lines of Chinese Hamster Ovary Cells (CHO) with Stable and High Level of Reporter Gene Expression.Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteinsHighly efficient cellular cloning using Ferro-core Micropallet Arrays.Beating the odds: The poisson distribution of all input cells during limiting dilution grossly underestimates whether a cell line is clonally-derived or not.Sustaining an efficient and effective CHO cell line development platform by incorporation of 24-deep well plate screening and multivariate analysis.Baicalein Reduces Oxidative Stress in CHO Cell Cultures and Improves Recombinant Antibody Productivity.A simple and scalable hydrogel-based system for culturing protein-producing cells.Transient expression of human antibodies in mammalian cells.Impact of host cell line choice on glycan profile.Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line.
P2860
Q27008285-BD759D9D-1C81-44FD-BBBF-60E502FAB817Q28071440-E2BFF9FE-2895-429D-B647-05FFE9847A35Q28544073-694FF1DD-A8F8-4E95-9DB9-2FF9B0C5D037Q31084451-438C96CE-3828-45E1-B22D-981D479652B5Q33690151-E82EEF6B-B1C2-45D6-A656-55652E96ED71Q34652077-2BE83173-7466-4E5A-93B3-F6011872B043Q35236588-CCDF48A3-92CF-445E-9FC2-F00008B413EEQ35649129-06313EFB-FCE8-486A-9666-E1D6D4015038Q35863259-ADEE749C-5816-4D4C-AD16-7780704D9564Q35893181-A93F4DE9-8358-488D-9879-CA14A0B541CBQ36525019-44A25014-8BB5-4CB3-8C4A-F83EC62D7D2EQ36532870-A3929F26-5D63-4961-8A68-A2CC45999FF7Q37494846-32627AB9-7B05-44C1-9E68-C6F3F53B92B6Q37652229-2DE6C1B2-D8F3-44B6-85E0-A8ABF5B5BC46Q37719187-F7A98D55-3107-477E-BAF0-DAABCABE8C22Q38159015-FF50D31E-AB85-472D-BAAB-3052F44B91BAQ38429852-A335931A-9751-4C43-AB64-5E8C55B93BB6Q38611817-A6864CF1-BD7B-42A0-A09D-FA2E01E31875Q38744210-6BBD3B64-40C4-4960-8755-4095D2EB7A78Q38765872-AC844698-3E4E-4C99-85A9-258C4FE34799Q38768666-31784AAB-E4F7-42DF-9C60-61A9440C3553Q38816515-ED4B66EE-FC9F-4CEE-AC05-1A90D42E7471Q38816648-418D4C37-C9DA-4EBB-8A88-0C743F879FE8Q38823012-689329AE-4D29-4DCC-B8AD-921EEED698E9Q38826159-13D1AC99-ED59-47B8-875E-80EB54BC4D60Q38834622-50419422-933F-44C3-B9F8-9228872833FBQ38847423-45ABD012-9365-4F73-A1D1-69F4156564A9Q39001735-E2AFA5A9-DEFF-4FFF-925A-168F19022CC9Q39061545-DB2975ED-3406-4742-89E9-BCC41A70AA45Q40606899-51A516D6-67D3-4AA5-A01A-B0D4FD1CCA2BQ41200519-BE8642C4-7190-4F0E-94A8-76BC8D784DABQ41986845-452F678B-52DA-4128-BCBA-4C59F36CC7E2Q42376096-5AC8155B-3EEC-4C8C-8679-40E4EEBF18E9Q46069564-906481A5-13E2-408D-AC4E-B719E99BEF16Q46259169-E34B2711-3039-4D22-8A56-BBA6A176E4A2Q46264094-F2116952-4753-4609-9B97-CE91021AE4A8Q47205410-226469D4-4EFC-429E-8687-B09F43569EA5Q47249953-F8F1DFA6-6BE1-4051-9079-C26D57A79400Q47269842-0DC3F556-AF63-46DD-9283-EAF66F1B7E8BQ47269867-B24A30D4-CC55-43A5-B02C-19211A8FE24F
P2860
Advances in Mammalian cell line development technologies for recombinant protein production.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in Mammalian cell lin ...... ecombinant protein production.
@en
Advances in Mammalian cell lin ...... ecombinant protein production.
@nl
type
label
Advances in Mammalian cell lin ...... ecombinant protein production.
@en
Advances in Mammalian cell lin ...... ecombinant protein production.
@nl
prefLabel
Advances in Mammalian cell lin ...... ecombinant protein production.
@en
Advances in Mammalian cell lin ...... ecombinant protein production.
@nl
P2093
P2860
P356
P1433
P1476
Advances in Mammalian cell lin ...... ecombinant protein production.
@en
P2093
Say Kong Ng
Tingfeng Lai
Yuansheng Yang
P2860
P304
P356
10.3390/PH6050579
P577
2013-04-26T00:00:00Z